Company intelligence / Profile preview

CHEMS

Englewood Cliffs, New Jersey, USAskate618.com ↗

Ownership: Private
Development stage: Other

Overview

LG Chem Life Sciences USA focuses on extending the global reach of medicines and therapeutics developed by its parent company. The pipeline includes programs at research, pre-clinical, clinical, and commercial stages. For example, their innovative obesity treatment LB54640 was advanced by Rhythm Pharmaceuticals as a key development project. No detailed clinical trial results are provided in the available sources.

Therapeutic areas: Endocrinology
Modalities: Small moleculeBiologicPeptidesmRNA-based drugs
Industry: Biotech

Partnerships

Rhythm Pharmaceuticals

Beyond the preview

Go deeper on CHEMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHEMS.

Explore the full profile